Oncology Central

Adjuvant chemotherapy and follow-up for recurrences in localized testicular cancer


Patients diagnosed with testicular germ cell tumor (seminoma and nonseminomatous germ cell tumor [NSGCT]) have one of the best prognoses of malignant neoplasms [1]. Following orchiectomy for stage I (testis confined) disease, management options include adjuvant chemotherapy and active surveillance. Although chemotherapy is associated with lower risk of relapse compared with surveillance, the long-term survival is excellent in both cases given the tumor’s exquisite sensitivity to cytotoxic drugs, particularly to bleomycin, etoposide and cisplatin (BEP).

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.




News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.